MEDEZRIN LTD.

Company Registration Number:
03340737 (England and Wales)

Unaudited statutory accounts for the year ended 31 March 2024

Period of accounts

Start date: 01 April 2023

End date: 31 March 2024

MEDEZRIN LTD.

Contents of the Financial Statements

for the Period Ended 31 March 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8
Balance sheet notes - 11

MEDEZRIN LTD.

Company Information

for the Period Ended 31 March 2024




Director: Rupert Holms
Secretary: Rupert Holms
Registered office: 71-75
Shelton Street
Covent Garden
London
GBR
WC2H 9JQ
Company Registration Number: 03340737 (England and Wales)

MEDEZRIN LTD.

Directors' Report Period Ended 31 March 2024

The directors present their report with the financial statements of the company for the period ended 31 March 2024

Principal Activities

Scientific and business consultancy

Directors

The directors shown below have held office during the whole of the period from 01 April 2023 to 31 March 2024
Rupert Holms

Secretary
Rupert Holms

This report was approved by the board of directors on 26 November 2024
And Signed On Behalf Of The Board By:

Name: Rupert Holms
Status: Director

MEDEZRIN LTD.

Profit and Loss Account

for the Period Ended 31 March 2024


Notes

2024
£

2023
£
Turnover 26,284 49,800
Cost of sales ( 47,820 ) ( 43,879 )
Gross Profit or (Loss) ( 21,536 ) 5,921
Administrative Expenses ( 34,575 ) ( 36,114 )
Operating Profit or (Loss) ( 56,111 ) ( 30,193 )
Interest Payable and Similar Charges ( 149 ) ( 154 )
Profit or (Loss) Before Tax ( 56,260 ) ( 30,347 )
Profit or (Loss) for Period ( 56,260 ) ( 30,347 )

The notes form part of these financial statements

MEDEZRIN LTD.

Balance sheet

As at 31 March 2024


Notes

2024
£

2023
£
Fixed assets
Tangible assets: 4 1,409 1,569
Total fixed assets: 1,409 1,569
Current assets
Debtors: 5 12,800
Cash at bank and in hand: 1,265 1,610
Total current assets: 14,065 1,610
Creditors: amounts falling due within one year: 6 ( 1,154,607 ) ( 1,089,437 )
Net current assets (liabilities): ( 1,140,542 ) ( 1,087,827 )
Total assets less current liabilities: ( 1,139,133 ) ( 1,086,258 )
Creditors: amounts falling due after more than one year: 7 ( 310,899 ) ( 307,514 )
Total net assets (liabilities): ( 1,450,032 ) ( 1,393,772 )

The notes form part of these financial statements

MEDEZRIN LTD.

Balance sheet continued

As at 31 March 2024


Notes

2024
£

2023
£
Capital and reserves
Called up share capital: 914 914
Revaluation reserve: 8 1,578,436 1,578,436
Profit and loss account: ( 3,029,382 ) ( 2,973,122 )
Shareholders funds: ( 1,450,032 ) ( 1,393,772 )

For the year ending 31 March 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 26 November 2024
And Signed On Behalf Of The Board By:

Name: Rupert Holms
Status: Director

The notes form part of these financial statements

MEDEZRIN LTD.

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

MEDEZRIN LTD.

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 2. Employees


    2024

    2023
    Average number of employees during the period 0 0

MEDEZRIN LTD.

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 3. Off balance sheet disclosure

    No

MEDEZRIN LTD.

Notes to the Financial Statements

for the Period Ended 31 March 2024

4. Tangible assets

Office equipment Total
Cost £ £
At 01 April 2023 1,569 1,569
Additions - -
Disposals - -
Revaluations - -
Transfers - -
At 31 March 2024 1,569 1,569
Depreciation
At 01 April 2023 - -
Charge for year 160 160
On disposals - -
Other adjustments - -
At 31 March 2024 160 160
Net book value
At 31 March 2024 1,409 1,409
At 31 March 2023 1,569 1,569

MEDEZRIN LTD.

Notes to the Financial Statements

for the Period Ended 31 March 2024

5. Debtors


2024
£

2023
£
Trade debtors 12,800
Total 12,800

MEDEZRIN LTD.

Notes to the Financial Statements

for the Period Ended 31 March 2024

6.Creditors: amounts falling due within one year note


2024
£

2023
£
Other creditors 1,154,607 1,089,437
Total 1,154,607 1,089,437

MEDEZRIN LTD.

Notes to the Financial Statements

for the Period Ended 31 March 2024

7.Creditors: amounts falling due after more than one year


2024
£

2023
£
Other creditors 310,899 307,514
Total 310,899 307,514

MEDEZRIN LTD.

Notes to the Financial Statements

for the Period Ended 31 March 2024

8. Revaluation reserve


2024
£
Balance at 01 April 2023 1,578,436
Surplus or deficit after revaluation 0
Balance at 31 March 2024 1,578,436